Similar articles

• Somatostatin receptor scintigraphy of malignant lymphoma--current status.

  Serafini AN. Serafini AN. Yale J Biol Med. 1997 Sep-Dec;70(5-6):555-9. Yale J Biol Med. 1997. PMID: 9825483 Free PMC article. Review. No abstract available.
• Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.

  Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ. Lipp RW, et al. J Nucl Med. 1995 Jan;36(1):13-8. J Nucl Med. 1995. PMID: 7799065 Clinical Trial.
• Somatostatin-receptor imaging in lymphoma.

  Goldsmith SJ, Macapinlac HA, O'Brien JP. Goldsmith SJ, et al. Semin Nucl Med. 1995 Jul;25(3):262-71. doi: 10.1016/s0001-2998(95)80015-8. Semin Nucl Med. 1995. PMID: 7570045 Review.
• Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.

  Bares R, Galonska P, Dempke W, Handt S, Büll U, Osieka R. Bares R, et al. Horm Metab Res Suppl. 1993;27:56-8. Horm Metab Res Suppl. 1993. PMID: 8330873
• Clinical experience with somatostatin receptor imaging in lymphoma.

  Bong SB, VanderLaan JG, Louwes H, Schuurman JJ. Bong SB, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):46-50. Semin Oncol. 1994. PMID: 7992081 No abstract available.